Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead

On Sept. 30, Pfizer announced a deal with the U.S. government that will allow the pharmaceutical leader to avoid President Donald Trump's tariffs for three years in exchange for slashing the prices of certain drugs in the U.S. and investing in local manufacturing efforts. This deal lifted not only Pfizer, but also much of the healthcare sector, especially the company's drugmaking peers, as Wall Street expects more deals along those lines.CRISPR Therapeutics (NASDAQ: CRSP) and BioNTech (NASDAQ: BNTX), two biotech companies, were among the winners. And the good news is that both stocks still have significant upside potential, although for reasons somewhat unrelated to these recent developments. Here is why CRISPR Therapeutics and BioNTech are worth serious consideration from investors.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool